Telomere Biology and Genomic Stability: Clinical Insights into Telomerase and Cellular Replicative Capacity

🩺
Medically Reviewed by Valley Clinic Editorial & Biotechnology Advisory Board
Compliant with clinical cGMP, NIH guidelines, and peer-reviewed pharmacology literature.

Telomeres—repetitive hexameric TTAGGG nucleotide sequences capping the termini of eukaryotic chromosomes—protect genomic DNA from end-to-end fusion and illegitimate repair. Replicative telomere attrition serves as an intrinsic cellular lifespan clock.

The Shelterin Protein Complex

Telomeric DNA is bound by a six-subunit protective protein complex called shelterin (TRF1, TRF2, RAP1, TIN2, TPP1, and POT1). Disruption of the shelterin complex exposes naked chromosome ends, activating the DNA Damage Response (DDR) and triggering permanent ATM/ATR-mediated p53 arrest.

Therapeutic Telomerase Activation

Transient telomerase reverse transcriptase (TERT) reactivation via mRNA or small-molecule activators has demonstrated preservation of tissue stem cell compartments without increasing spontaneous oncogenesis in preclinical models.